Tarlatamab (AMG-757)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tarlatamab (AMG-757), covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311) [Phase 1]